Vincent, Jean-Louis <br/><br/>
Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.  [electronic resource] 

 -  Critical care (London, England)  Aug 2005 
 - R331-43 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1466-609X 
<br/><br/><label>Standard No.: </label>10.1186/cc3538  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Infective Agents--therapeutic use<br/>Child<br/>Child, Preschool<br/>Comorbidity<br/>Female<br/>Hemorrhage--epidemiology<br/>Humans<br/>IgA Vasculitis--epidemiology<br/>Intracranial Hemorrhages--epidemiology<br/>Male<br/>Meningitis, Bacterial--epidemiology<br/>Meningococcal Infections--epidemiology<br/>Middle Aged<br/>Odds Ratio<br/>Protein C--therapeutic use<br/>Recombinant Proteins--therapeutic use<br/>Retrospective Studies<br/>Sepsis--drug therapy<br/>Survival Analysis<br/>Treatment Outcome